Groowe Groowe BETA

US Stock Market News

Stay on top of the US stock market with real-time breaking news and market-moving stories. Our platform continuously aggregates updates from trusted financial news sources, giving traders and investors a fast overview of events that may impact stock prices.

Whether you're tracking specific companies or scanning the broader market, the news feed helps you quickly identify important developments as they happen.

Create an account to access the live news feed. Access is free while the platform is in beta. Visitors without an account can still browse the latest headlines with a 15-minute delay.

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

HDFC Bank Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - HDB

prnewswire.com
HDB

SereneDB Launches Krummelanke: The Fastest Search and Analytical Engine Enabling the Agentic Future

accessnewswire.com
NVDA AMZN

Pharming announces positive Phase II topline data for leniolisib in PIDs with immune dysregulation accepted as late-breaking abstract at ESID 2026

globenewswire.com
PHAR

Hitachi Rail launches ‘Enhanced by HMAX™’, committing to embed technology in all new rolling stock from 2027

globenewswire.com
NVDA

Shareholders of Aardvark Therapeutics, Inc. (AARD): Protect Your Rights Before October 13, 2026 - Contact Levi & Korsinsky

accessnewswire.com
AARD

Securities Lawsuit Alert: Aardvark Therapeutics, Inc. (AARD) - Contact Levi & Korsinsky Before October 13, 2026

accessnewswire.com
AARD

Investors Urged to Contact Levi & Korsinsky for Information Before October 13, 2026 - Aardvark Therapeutics, Inc. (AARD)

accessnewswire.com
AARD

Omdia: Mainland China PC market grows 11% in Q2, shipments forecast to fall 6% in 2026

businesswire.com
TTGT

On Enters Next Chapter: Unveils Strategy to Redefine What a Sportswear Brand Can Be Alongside 2029 Financial Targets

businesswire.com
ONON

BoomRay Enters Exclusive Global License Agreement with Novartis for a Novel Radioligand Therapy Asset

prnewswire.com
NVS
View all news →